Abstract:Eosinophils are involved in the development of asthma exacerbation. Recent studies have suggested that sputum and blood eosinophil counts are important factors for predicting asthma exacerbation. In severe eosinophilic asthma, anti-interleukin (IL)-5 monoclonal antibody decreases blood eosinophil count and asthma exacerbation frequency. However, even in the absence of IL-5, eosinophilic airway inflammation can be sufficiently maintained by the T helper (Th) 2 network, which comprises a cascade of vascular cell adhesion molecule-1/CC chemokines/eosinophil growth factors, including granulocyte-macrophage colony-stimulating factor (GM-CSF). Periostin, an extracellular matrix protein and a biomarker of the Th2 immune response in asthma, directly activates eosinophils in vitro. A major cause of asthma exacerbation is viral infection, especially rhinovirus (RV) infection. The expression of intercellular adhesion molecule (ICAM)-1, a cellular receptor for the majority of RVs, on epithelial cells is increased after RV infection, and adhesion of eosinophils to ICAM-1 can upregulate the functions of eosinophils. The expressions of cysteinyl leukotrienes (cysLTs) and CXCL10 are upregulated in virus-induced asthma. CysLTs can directly provoke eosinophilic infiltration in vivo and activate eosinophils in vitro. Furthermore, eosinophils express the CXC chemokine receptor 3, and CXCL10 activates eosinophils in vitro. Both eosinophils and neutrophils contribute to the development of severe asthma or asthma exacerbation. IL-8, which is an important chemoattractant for neutrophils, is upregulated in some cases of severe asthma. Lipopolysaccharide (LPS), which induces IL-8 from epithelial cells, is also increased in the lower airways of corticosteroid-resistant asthma. IL-8 or LPS-stimulated neutrophils increase the transbasement membrane migration of eosinophils, even in the absence of chemoattractants for eosinophils. Therefore, eosinophils are likely to contribute to the development of asthma exacerbation through several mechanisms, including activation by Th2 cytokines, such as IL-5 or GM-CSF or by virus infection-related proteins, such as CXCL10, and interaction with other cells, such as neutrophils.

Involvement of autophagy in exacerbation of eosinophilic airway inflammation in a murine model of obese asthma

Obesity Enhances Non-Th2 Airway Inflammation in a Murine Model of Allergic Asthma

Eosinophils prevent diet-induced airway hyperresponsiveness in mice on a high-fat diet

Oncostatin M Expression Induced by Bacterial Triggers Drives Airway Inflammatory and Mucus Secretion in Severe Asthma.

Diet-induced obesity worsens allergen-induced type 2/type 17 inflammation in airways by enhancing DUOX1 activation

Innate lymphoid cells contribute to allergic airway disease exacerbation by obesity

IL-17 Protein Levels in Both Induced Sputum and Plasma Are Increased in Stable but Not Acute Asthma Individuals with Obesity.

Airway Epithelial ATG5 Suppresses Asthmatic Inflammation in Mice

The regulatory role of eosinophils in adipose tissue depends on autophagy

Inhibition of soluble epoxide hydrolase relieves adipose inflammation via modulating M1/M2 macrophage polarization to alleviate airway inflammation and hyperresponsiveness in obese asthma

Involvement and Possible Role of Eosinophils in Asthma Exacerbation

Obesity alters inflammatory response in the pathology of asthma (Review)

Impact of obesity on airway remodeling in asthma: pathophysiological insights and clinical implications

ORMDL3‐mediated bronchial epithelial pyroptosis leads to lung inflammation in obese mice with asthma

Systemic bile acids potentiate airway hyperresponsiveness and modulate Th17 cell function in obesity-associated asthma

High-fat diet and palmitic acid amplify airway type 2 inflammation

Interactive Effects Between Obesity and Atopy on Inflammation

Dissociation between lung inflammation and hyperresponsiveness in a murine model of obesity

Body Weight and Allergic Asthma: A Narrative Review

HDM-induced Atg5 Mediates TSLP Expressing to Disrupt Epithelial Barrier

Obesity-Related Asthma: Immune Regulation And Potential Targeted Therapies